Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients

ISSN
1527-7755
0732-183X
Date Issued
2014
Author(s)
Herrlinger, Ulrich
Schaefer, Nildas
Steinbach, Joachim Peter
Weyerbrock, Astrid
Hau, Peter
Goldbrunner, Roland
Friedrich, Franziska
Ringel, Florian
Braun, Christian
Kohnen, Ralf
Leutgeb, Barbara
Belka, Claus
Urbach, Horst
Stummer, Walter
Gies, Martin